Literature DB >> 330759

Macrophage activation for tumor cytotoxicity: induction of tumoricidal macrophages by supernatants of PPD-stimulated Bacillus Calmette-Guérin-immune spleen cell cultures.

L P Ruco, M S Meltzer.   

Abstract

Resident peritoneal macrophages from normal mice were activated for tumor cytotoxicity in vitro by co-cultivation with BCG1-immune spleen cells and PPD and by incubation with supernatants of PPD-stimulated BCG-immune spleen cell cultures (lymphokine supernatants). Lymphokine activation of macrophages occurred in unfractionated PC suspensions as well as in macrophage monolayers depleted of nonadherent PC. Tumor cytotoxicity by lymphokine-activated macrophages was evident by 3 to 4 hr of culture in active supernatants, reached maximal levels by 8 to 12 hr. and was absent by 20 hr. Continued incubation in lymphokines or even re-exposure after washing did not maintain macrophage cytotoxicity. The capacity of normal resident macrophages to be activated by lymphokines in vitro progressively decreased and was absent by 20 hr in culture. This decrease did not necessarily reflect cell death; macrophage viability as estimated by exclusion of trypan blue or by phagocytic responses did not change over the 20-hr culture period. The short lived nature of both macrophage tumoricidal capacity and capacity of precursor cells to be activated by lymphokines may function as negative feedback mechanisms in immune reactions.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 330759

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  Host defenses in experimental scrub typhus: role of normal and activated macrophages.

Authors:  C A Nacy; J V Osterman
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

2.  Immunoreactivity for IL-1 beta and TNF alpha in human lymphoid and nonlymphoid tissues.

Authors:  L P Ruco; A Stoppacciaro; D Pomponi; D Boraschi; A Santoni; A Tagliabue; S Uccini; C D Baroni
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307

3.  Evaluation of macrophage plasticity in brown and white adipose tissue.

Authors:  M Teresa Ortega; Linglin Xie; Silvia Mora; Stephen K Chapes
Journal:  Cell Immunol       Date:  2011-06-23       Impact factor: 4.868

4.  The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infections.

Authors:  J Drews
Journal:  Infection       Date:  1985       Impact factor: 3.553

5.  Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involves the iron-sulfur prosthetic group and is reversible.

Authors:  J C Drapier; J B Hibbs
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

6.  Rate and efficiency of complement-dependent phagocytosis in cytolytic and non-cytolytic inflammatory macrophages.

Authors:  A J Norin; R A De Pinho
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

Review 7.  The biochemistry and in vitro activity of soluble factors of activated lymphocytes.

Authors:  C Sorg
Journal:  Mol Cell Biochem       Date:  1979-12-14       Impact factor: 3.396

Review 8.  Macrophage infiltration and tumor progression.

Authors:  S J Normann
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

9.  Differential inhibition of macrophage microbicidal activity by liposomes.

Authors:  M J Gilbreath; G M Swartz; C R Alving; C A Nacy; D L Hoover; M S Meltzer
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

10.  Cytotoxicity of human macrophages for tumor cells. Enhancement by human lymphocyte mediators.

Authors:  D J Cameron; W H Churchill
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.